Related Experiment Video
Updated: Jul 10, 2026
07:00
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
Cognitive impairment in amyotrophic lateral sclerosis
Julie Phukan1, Niall P Pender, Orla Hardiman
1Department of Neurology, Beaumont Hospital, Dublin, Ireland. juliephukan@yahoo.co.uk
The Lancet. Neurology
|October 20, 2007
Summary
Amyotrophic lateral sclerosis (ALS) affects the motor system but also impacts cognition. Research shows significant overlap with frontotemporal dementia, highlighting the need for better assessment and understanding of cognitive changes in ALS patients.
Area of Science:
- Neuroscience
- Neurology
- Cognitive Science
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease affecting adults.
- While primarily a motor system disorder, cognitive and behavioral symptoms are increasingly recognized in ALS.
- ALS shares clinical, pathological, and genetic links with frontotemporal dementia.
Purpose of the Study:
- To review evidence of non-motor system involvement in ALS.
- To examine cognitive impairment and neuropsychological test results in ALS.
- To provide guidance on assessing frontotemporal dysfunction in ALS patients.
Main Methods:
- Review of genetic, imaging, and neuropathological studies.
- Analysis of research on cognitive impairment in ALS.
- Synthesis of findings on frontotemporal dementia overlap.
Main Results:
- Cognitive decline in ALS includes personality changes and executive function deficits, mirroring frontotemporal dementia.
- Genetic, imaging, and neuropathological data confirm non-motor system involvement.
- Specific neuropsychological tests reveal common patterns of impairment.
Conclusions:
- Cognitive impairment is a significant feature of ALS, linked to frontotemporal dementia.
- Understanding these cognitive aspects is crucial for patient care and neurodegeneration research.
- Further research is needed to fully elucidate frontotemporal dysfunction in ALS.
More Related Videos
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.